Showing results (331-340 of 689) with videos related to

Sort By:
Pageof 69
Annals of Internal Medicine|August 15, 1997
Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospitalW H Maisel, K M Kuntz, S C Reimold, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
High-dose ifosfamide, carboplatin, and etoposide pharmacokinetics: correlation of plasma drug levels with renal toxicityJ E Wright, A Elias, O Tretyakov, et al.
The American Journal of Cardiology|July 1, 1990
Analysis of possible triggers of acute myocardial infarction (the MILIS study)G H Tofler, P H Stone, M Maclure, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Trimetrexate in malignant mesothelioma: A Cancer and Leukemia Group B Phase II studyN J Vogelzang, L B Weissman, J E Herndon, et al.
Thrombosis and Haemostasis|September 13, 2020
Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 TrialGiuseppe Boriani, Christian T Ruff, Julia F Kuder, et al.
Journal of Clinical and Translational Science|August 9, 2021
An overview of the process, progress, and outcomes of a National Center for Accelerated Innovation: The Boston Biomedical Innovation Center ExperienceElliott M Antman, Mason W Freeman, David E Golan, et al.
Circulation|April 1, 1988
Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectorisJ D Horowitz, C A Henry, M L Syrjanen, et al.
American Heart Journal|April 26, 2001
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhageR P Giugliano, C H McCabe, E M Antman, et al.
Pageof 69